Our experience with rituximab therapy for adult-onset primary glomerulonephritis and review of literature.
about
Rituximab use in adult primary glomerulopathy: where is the evidence?Rituximab shows no effect on remission in patients with refractory nephrotic syndrome: A MOOSE-compliant meta-analysis.The efficacy and safety of rituximab in treating childhood refractory nephrotic syndrome: a meta-analysisRituximab treatment for relapsing minimal change disease and focal segmental glomerulosclerosis: a systematic review.Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies.Rituximab therapy for primary glomerulonephritis: Report on two casesC3 Glomerulopathy.
P2860
Q28075564-1CDDB6F9-1D94-47D3-855A-1777F23649ADQ30240107-901CF7A4-C594-44EF-B528-A425F07A88D9Q35040896-A436B940-460B-47B8-834F-9CE053B4FFB7Q38206050-D4D59FBB-7618-4B1C-BDBA-AEC9F1E1326CQ38749694-FEE2E801-CD4E-4CF5-820D-B4AFB5F1D305Q41036642-FD335ABC-DA5A-47B1-942F-2F051D5B0A5AQ52876323-5BAF2434-3BC9-4747-91CE-4F726FFCB41A
P2860
Our experience with rituximab therapy for adult-onset primary glomerulonephritis and review of literature.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Our experience with rituximab ...... itis and review of literature.
@en
type
label
Our experience with rituximab ...... itis and review of literature.
@en
prefLabel
Our experience with rituximab ...... itis and review of literature.
@en
P2860
P1476
Our experience with rituximab ...... ritis and review of literature
@en
P2093
Ramyasuda Swaminathan
Wai Yew Kong
P2860
P304
P356
10.1007/S11255-012-0206-0
P577
2012-07-15T00:00:00Z